Changes in salivary prostaglandin levels during menstrual migraine with associated dysmenorrhea

Headache

Volumn 50, Issue 5, 2010, Pages 844-851

  Durham, Paul L ^a   Vause, Carrie V ^a   Derosier, Frederick ^b   McDonald, Susan ^b   Cady, Roger ^c   Martin, Vincent ^d  

^a MISSOURI STATE UNIVERSITY   (United States)

^b GLAXOSMITHKLINE   (United States)

^c Banyan Group Inc   (United States)

^d UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Dysmenorrhea; Migraine; Prostaglandins; Saliva

Indexed keywords

NAPROXEN; PLACEBO; PROSTACYCLIN; PROSTAGLANDIN; PROSTAGLANDIN D2; PROSTAGLANDIN E2; PROSTAGLANDIN F2; SUMATRIPTAN SUCCINATE; THROMBOXANE A2; TREXIMET; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG RESPONSE; DYSMENORRHEA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MENSTRUAL MIGRAINE; PILOT STUDY; PRIORITY JOURNAL; SALIVA LEVEL; TABLET;

ADULT; DOUBLE-BLIND METHOD; DYSMENORRHEA; FEMALE; HUMANS; MIDDLE AGED; MIGRAINE DISORDERS; NAPROXEN; PREMENSTRUAL SYNDROME; PROSTAGLANDINS; SALIVA; SEROTONIN RECEPTOR AGONISTS; SUMATRIPTAN; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77951885776     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2010.01657.x     Document Type: Article

References (38)

1. International Headache Society. The international classification of headache disorders: 2nd edition. Cephalalgia. 2004 24 (Suppl. 1 1 160.
2. Martin VT, Behbehani M. Ovarian hormones and migraine headache: Understanding mechanisms and pathogenesis - Part 2. Headache. 2006 46 : 365 386.
3. Martin VT, Wernke S, Mandell K, et al. Symptoms of premenstrual syndrome and their association with migraine headache. Headache. 2006 46 : 125 137.
4. Ylikorkala O, Dawood MY. New concepts in dysmenorrhea. Am J Obstet Gynecol. 1978 130 : 833 847. (Pubitemid 8299811)
5. Baker FC, Driver HS, Rogers GG, Paiker J, Mitchell D. High nocturnal body temperatures and disturbed sleep in women with primary dysmenorrhea. Am J Physiol. 1999 277 : E1013 E1021. (Pubitemid 30045994)
6. Mannix LK. Menstrual-related pain conditions: Dysmenorrhea and migraine. J Womens Health. 2008 17 : 879 891.
7. Nattero G, Allais G, De Lorenzo C, et al. Relevance of prostaglandins in true menstrual migraine. Headache. 1989 29 : 233 238. (Pubitemid 20346772)
8. Al-Waili NS. Treatment of menstrual migraine with prostaglandin synthesis inhibitor mefenamic acid: Double-blind study with placebo. Eur J Med Res. 2000 5 : 176 182.
9. Mohammadian P, Hummel T, Arora C, Carpenter T. Peripheral levels of inflammatry mediators in migraineurs druing headache-free periods. Headache. 2001 41 : 867 872. (Pubitemid 33043150)
10. Milsom I, Minic M, Dawood MY, et al. Comparison of the efficacy and safety of nonprescription doses of naproxen and naproxen sodium with ibuprofen, acetaminophen, and placebo in the treatment of primary dysmenorrhea: a pooled analysis of five studies. Clin Ther. 2002 24 : 1384 1400. (Pubitemid 35176971)
11. Martin V, Mannix L, Ballard J, Derosier F, Lener S, McDonald S. Relief of menstrual symptoms and migraine after early treatment with a fixed single-tablet formulation of sumatriptan with RT technology and naproxen sodium (SumaRT/Nap). Neurology. 2008 70 : A355.
12. Mannix LK, Martin VT, Cady RK, et al. Combination treatment for menstrual migraine and dysmenorrhea using sumatriptan-naproxen: Two randomized controlled trials. Obstet Gynecol. 2009 114 : 106 113.
13. Mohammadian P, Hummel T, Arora C, Carpenter T. Peripheral levels of inflammatory mediators in migraineurs during headache-free periods. Headache. 2001 41 : 867 872. (Pubitemid 33043150)
14. Puig-Parellada P, Planas JM, Gimenez J, et al. Plasma and saliva levels of PGI2 and TXA2 in the headache-free period of classical migraine patients. The effects of nicardipine. Headache. 1991 31 : 156 158.
15. Nicolodi M, Del Bianco E. Sensory neuropeptides (substance P, calcitonin gene-related peptide) and vasoactive intestinal polypeptide in human saliva: Their pattern in migraine and cluster headache. Cephalalgia. 1990 10 : 39 50.
16. Bellamy J, Cady R, Durham P. Salivary levels of CGRP and VIP in rhinosinusitis and migraine patients. Headache. 2006 46 : 24 33.
17. Cady R, Vause C, Ho T, Bigal M, Durham P. Elevated saliva calcitonin gene-related peptide levels during acute migraine predict therapeutic response to rizatriptan. Headache. 2009 49 : 1258 1266.
18. Brandes JL, Smith T, Diamond M, Ames MH. Open-label, long-term tolerability of naratriptan for short-term prevention of menstrually related migraine. Headache. 2007 47 : 886 894. (Pubitemid 46944387)
19. Durham P, Russo A. Stimulation of the calcitonin gene-related peptide enhancer by mitogen-activated protein kinases and repression by an antimigraine drug in trigeminal ganglia neurons. J Neurosci. 2003 23 : 807 815. (Pubitemid 36206171)
20. Allais G, Bussone G, De Lorenzo C, et al. Naproxen sodium in short-term prophylaxis of pure menstrual migraine: Pathophysiological and clinical considerations. Neurol Sci. 2007 28 (Suppl. 2 S225 S228. (Pubitemid 46813659)
21. Evers S, Afra J, Frese A, et al. EFNS guideline on the drug treatment of migraine - Revised report of an EFNS task force. Eur J Neurol. 2009 16 : 968 981. (Pubitemid 43873628)
22. Brandes JL, Kudrow D, Stark SR, et al. Sumatriptan-naproxen for acute treatment of migraine: A randomized trial. JAMA. 2007 297 : 1443 1454. (Pubitemid 46556470)
23. Sarchielli P, Alberti A, Codini M, Floridi A, Gallai V. Nitric oxide metabolites, prostaglandins and trigeminal vasoactive peptides in internal jugular vein blood during spontaneous migraine attacks. Cephalalgia. 2000 20 : 907 918. (Pubitemid 32336718)
24. Vardi J, Flechter S, Alguati A, Regev I, Ayalon D. Prostaglandin - E2 levels in the saliva of common migrainous women. Headache. 1983 23 : 59 61. (Pubitemid 13165417)
25. Tuca JO, Planas JM, Parellada PP. Increase in PGE2 and TXA2 in the saliva of common migraine patients. Action of calcium channel blockers. Headache. 1989 29 : 498 501.
26. Simmons DL, Botting RM, Hla T. Cyclooxygenase isozymes: The biology of prostaglandin synthesis and inhibition. Pharmacol Rev. 2004 56 : 387 437. (Pubitemid 39096597)
27. Critchley HO, Jones RL, Lea RG, et al. Role of inflammatory mediators in human endometrium during progesterone withdrawal and early pregnancy. J Clin Endocrinol Metab. 1999 84 : 240 248.
28. Jenkins DW, Feniuk W, Humphrey PP. Characterization of the prostanoid receptor types involved in mediating calcitonin gene-related peptide release from cultured rat trigeminal neurones. Br J Pharmacol. 2001 134 : 1296 1302. (Pubitemid 33097260)
29. Abdel-Halim MS, Hamberg M, Sjoquist B, Anggard E. Identification of prostaglandin D2 as a major prostaglandin in homogenates of rat brain. Prostaglandins. 1977 14 : 633 643. (Pubitemid 8202759)
30. Liang X, Wu L, Hand T, Andreasson K. Prostaglandin D2 mediates neuronal protection via the DP1 receptor. J Neurochem. 2005 92 : 477 486. (Pubitemid 40189451)
31. Urade Y, Hayaishi O. Prostaglandin D synthase: Structure and function. Vitam Horm. 2000 58 : 89 120.
32. Vesin MF, Barakat-Walter I, Droz B. Preferential synthesis of prostaglandin D2 by neurons and prostaglandin E2 by fibroblasts and nonneuronal cells in chick dorsal root ganglia. J Neurochem. 1991 57 : 167 174.
33. Kadoi J, Takeda M, Matsumoto S. Prostaglandin E2 potentiates the excitability of small diameter trigeminal root ganglion neurons projecting onto the superficial layer of the cervical dorsal horn in rats. Exp Brain Res. 2007 176 : 227 236. (Pubitemid 44837098)
34. Jabbour HN, Sales KJ. Prostaglandin receptor signalling and function in human endometrial pathology. Trends Endocrinol Metab. 2004 15 : 398 404.
35. Kaufman E, Lamster IB. The diagnostic applications of saliva - A review. Crit Rev Oral Biol Med. 2002 13 : 197 212. (Pubitemid 34791218)
36. Lawrence HP. Salivary markers of systemic disease: Noninvasive diagnosis of disease and monitoring of general health. J Can Dent Assoc. 2002 68 : 170 174.
37. Li Y, Denny P, Ho CM, et al. The Oral Fluid MEMS/NEMS Chip (OFMNC): Diagnostic and translational applications. Adv Dent Res. 2005 18 : 3 5.
38. Segal A, Wong DT. Salivary diagnostics: Enhancing disease detection and making medicine better. Eur J Dent Educ. 2008 12 (Suppl. 1 22 29.